Cytogenetics is the branch of genetics that examines chromosomes under the microscope and, increasingly, through molecular and digital methods to detect changes in their number, structure, or behavior. The field traces its modern roots to the 1950s, when researchers first established that human cells carry 46 chromosomes, and it has since expanded into one of the most practically useful areas of medical genetics. Whether a doctor is diagnosing a developmental condition in a newborn, classifying a blood cancer, or screening a pregnancy, cytogenetic analysis is often the test that provides the answer.
Counting to 46
For more than three decades in the early twentieth century, textbooks confidently stated that humans have 48 chromosomes. That number was wrong. In December 1955, Joe Hin Tjio and Albert Levan, working at the University of Lund in Sweden, used improved cell-culture and slide-preparation techniques to count the chromosomes in human tissue and arrived at 46. Their finding was published in April 1956, correcting an error that had persisted since the 1920s.1PubMed. The discovery of the human chromosome number in Lund, 1955-1956 That correction mattered enormously: with the right number in hand, researchers could finally spot when a patient had one chromosome too many or too few and begin connecting chromosome abnormalities to specific conditions.
Karyotyping and Banding
The workhorse of classical cytogenetics is the karyotype, a photograph or digital image of all 46 chromosomes from a single cell, arranged in pairs from largest to smallest. To produce one, a lab technician collects cells (often from blood, bone marrow, or amniotic fluid), coaxes them to divide, then arrests them at the stage of division when chromosomes are most condensed and visible. The chromosomes are spread on a glass slide, stained, and photographed.
What makes individual chromosomes distinguishable from one another is banding. Several staining methods produce characteristic patterns of light and dark stripes along each chromosome. The most common is G-banding, which uses an enzyme treatment followed by Giemsa stain to create a barcode-like pattern unique to each chromosome pair.2Current Protocols in Cell Biology. Traditional Banding of Chromosomes for Cytogenetic Analysis Other approaches, including Q-banding (which uses fluorescent dyes) and R-banding (which reverses the light-dark pattern), produce virtually identical band patterns along the length of human chromosomes, though each highlights slightly different features.3PubMed. Chromosome banding techniques A trained cytogeneticist can look at a banded karyotype and spot missing segments, extra copies, or rearrangements that would be invisible without the stain.
Protocols for preparing chromosomes from both human and mouse tissues continue to be refined. Modern laboratories combine conventional G-banding with molecular methods such as fluorescence in situ hybridization (FISH) and spectral karyotyping on the same samples, letting a single preparation answer both broad and targeted questions.4PubMed Central. Protocol for preparation and staining of chromosomes isolated from mouse and human tissues for conventional and molecular cytogenetic analysis
When the Chromosome Count Is Wrong
Having an extra or missing chromosome is called aneuploidy, and it is the most common type of chromosome abnormality detected by cytogenetics. Trisomy 21 (Down syndrome), in which cells carry three copies of chromosome 21 instead of two, is the best-known example. But trisomies of other chromosomes also occur: trisomy 18 (Edwards syndrome), trisomy 16 (common in miscarriages), and trisomy 13 (Patau syndrome) each have distinct clinical pictures.
The mechanism behind most trisomies is nondisjunction, a failure of chromosomes to separate properly during the formation of eggs or sperm. Maternal errors during the first stage of egg-cell division are the single largest class of nondisjunction events, though the specifics vary by chromosome. For chromosomes 15 and 21, errors in that first division predominate, whereas trisomy 18 more often arises from errors in the second division. Trisomy 16 is almost entirely caused by first-division errors in the mother.5Human Reproduction. Origin and mechanisms of non-disjunction in human autosomal trisomies A smaller fraction of trisomies, roughly 5 to 15 percent for chromosomes 15, 18, and 21, arise after fertilization from errors in early cell divisions of the embryo.5Human Reproduction. Origin and mechanisms of non-disjunction in human autosomal trisomies
Why does maternal age increase the risk? The short answer is that the egg cell’s division machinery sits paused for decades before ovulation, and the protein structures that hold chromosome pairs together gradually degrade. Research on chromosome 21 has shown that abnormal patterns of genetic exchange between chromosome copies interact with age-related factors, though the exact mechanism remains surprisingly poorly understood despite decades of study.6PubMed Central. New Insights into Human Nondisjunction of Chromosome 21 in Oocytes7PubMed Central. Etiology of Down syndrome: Evidence for consistent association among altered meiotic recombination, nondisjunction, and maternal age across populations
Structural Rearrangements
Chromosomes do not only go missing or appear in extra copies. Pieces of chromosomes can break off and reattach in the wrong place, flip upside down, or fuse with another chromosome entirely. These structural changes include translocations (a segment moves from one chromosome to another), inversions (a segment flips orientation), deletions (a segment is lost), and duplications (a segment is copied).
A Robertsonian translocation is a special case in which two chromosomes fuse at their centers, reducing the total count by one even though virtually all the genetic material remains. Studies in mice carrying a Robertsonian translocation involving chromosomes 11 and 13 showed that these animals had 39 chromosomes instead of the normal 40, and while the fused chromosome did not disrupt early stages of sperm development, it caused programmed cell death in later-stage sperm cells and a reduced count of mature sperm.8PubMed Central. Chromosome aberrations and spermatogenic disorders in mice with Robertsonian translocation (11; 13) This kind of translocation is directly relevant to humans: Robertsonian translocations involving chromosome 21 are a known cause of familial Down syndrome, and they can reduce fertility in carriers.
The Philadelphia Chromosome and Cancer Cytogenetics
One of the most celebrated discoveries in all of cytogenetics came from cancer research. In 1960, researchers in Philadelphia noticed an unusually small chromosome in the blood cells of patients with chronic myelogenous leukemia (CML). That abnormal chromosome, named the Philadelphia chromosome, turned out to be the result of a translocation between chromosomes 9 and 22. The swap puts two genes, BCR and ABL, next to each other, creating a fused gene whose protein product is a permanently active enzyme that drives uncontrolled cell growth.9PubMed Central. Applying the discovery of the Philadelphia chromosome10PubMed. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics
The BCR-ABL fusion protein signals through multiple growth and survival pathways inside the cell, pushing white blood cell precursors to multiply without the usual brakes.11PubMed. BCR-ABL: The molecular mastermind behind chronic myeloid leukemia Understanding this led directly to the development of imatinib (Gleevec), a drug designed to block the BCR-ABL enzyme. Imatinib transformed CML from a near-certain death sentence into a manageable chronic condition for most patients, and it became the poster child for targeted cancer therapy.9PubMed Central. Applying the discovery of the Philadelphia chromosome Today, cytogenetic analysis of tumor cells is routine in the diagnosis and classification of leukemias, lymphomas, and many solid tumors. The specific chromosomal rearrangements found in a cancer often determine which drugs are used and what the prognosis looks like.
Prenatal Chromosome Screening
Cytogenetics plays a central role in prenatal care. For decades, the gold standard for detecting fetal chromosome abnormalities was amniocentesis or chorionic villus sampling, both of which involve collecting fetal cells for karyotyping. These procedures are highly accurate but carry a small risk of miscarriage.
Non-invasive prenatal testing (NIPT), which analyzes fragments of fetal DNA circulating in the mother’s blood, has changed the landscape. A study comparing NIPT to amniocentesis found that NIPT was as accurate as the invasive test for detecting trisomy 21, raising the possibility that procedure-related miscarriages could be reduced by reserving amniocentesis for cases where NIPT flags a concern.12PubMed Central. Comparing Non-invasive Prenatal Testing With Invasive Testing for the Detection of Trisomy 21 Systematic reviews have continued to evaluate the diagnostic accuracy of cell-free DNA testing by comparing results to those of invasive diagnostic methods and karyotyping.13PubMed Central. Diagnostic accuracy of cell-free DNA-based non-invasive prenatal testing for fetal aneuploidies: a systematic review NIPT is a screening test, though, not a definitive diagnosis. A positive NIPT result still typically leads to amniocentesis for confirmation, because false positives do occur, especially for rarer conditions.
Sex Chromosome Conditions
The sex chromosomes, X and Y, are fertile ground for cytogenetic findings. Turner syndrome results from having a single X chromosome (written 45,X), while Klinefelter syndrome involves an extra X (47,XXY). Both are surprisingly common, but they are often diagnosed late. A cytogenetic series from eastern Libya found that the median age at diagnosis for Turner syndrome was 9 years and for Klinefelter syndrome a striking 29 years, with six out of seven Klinefelter patients diagnosed only in adulthood, usually because of infertility.14Libyan Journal of Medical Research. Delayed Diagnosis of Sex-Chromosome Aneuploidies in Eastern Libya: Turner and Klinefelter Syndromes in a Five-Year Cytogenetic Series from the First International Laboratory, Benghazi (2021–2025) This diagnostic delay is not unique to any one region; sex chromosome aneuploidies are underrecognized worldwide because their features can be subtle.
Mosaic forms, in which only some cells carry the abnormal chromosome count, tend to produce milder symptoms. A decade-long study at a single medical center found that people with mosaic Klinefelter syndrome lacked some of the features seen in the classic form, such as tall stature, delayed puberty, and congenital heart defects.15PubMed Central. Genotype–Phenotype Correlations in Klinefelter and Turner Syndrome: A Decade of Sex Chromosome Aneuploidy Data From a Single Academic Medical Center The effect of sex chromosome changes also ripples far beyond the X and Y themselves. Genomic studies of Turner and Klinefelter patients revealed widespread changes in gene activity across every chromosome, not just the sex chromosomes, demonstrating that the copy number of X has genome-wide consequences.16PubMed Central. Integrated functional genomic analyses of Klinefelter and Turner syndromes reveal global network effects of altered X chromosome dosage
How do females normally tolerate having two X chromosomes when males function with one? Through X-chromosome inactivation, a process in which a long non-coding RNA molecule called XIST coats one X chromosome in every female cell and silences it, compacting it into a dense structure known as the Barr body.17PubMed Central. XIST RNA and architecture of the inactive X chromosome: implications for the repeat genome18PubMed Central. Mechanistic insights in X-chromosome inactivation This inactivation is why having an extra or missing X produces effects rather than being fully compensated: some genes on the X escape silencing, and their dosage matters.
Fragile X and Repeat Expansions
Fragile X syndrome, the most common inherited cause of intellectual disability, gets its name from how a specific site on the X chromosome looks under the microscope: the tip of the long arm appears to dangle, as if it could break off. The underlying cause is an expansion of a short DNA sequence (CGG) that repeats over and over in the FMR1 gene. In unaffected people, this stretch contains fewer than about 45 repeats. In carriers known as premutation carriers, it reaches roughly 55 to 200 repeats, and in people with the full syndrome, it expands past 200.19PubMed Central. Fragile X syndrome: the FMR1 CGG repeat distribution among world populations
The instability of these repeats is remarkable. A large international collaboration found that premutation alleles with as few as 59 repeats could expand to a full mutation (over 200 repeats) in a single generation when passed from mother to child, especially when the repeat lacked certain stabilizing interruptions.20PubMed Central. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles Once expanded and chemically modified, the repeat region can form unusual DNA structures that suppress the gene’s activity, effectively shutting down production of the protein the brain needs for normal development.21PubMed. The fragile X syndrome d(CGG)n nucleotide repeats form a stable tetrahelical structure Cytogenetic testing for fragile X has now been largely replaced by direct molecular measurement of repeat length, but the condition’s name preserves its cytogenetic origin.
Molecular and Digital Cytogenetics
Classical karyotyping can detect changes involving several million base pairs or more of DNA, but many clinically important alterations are smaller than that. Molecular cytogenetic techniques bridge the gap. FISH uses fluorescent DNA probes that bind to specific chromosome regions and light up under a microscope, allowing a lab to ask targeted questions: is this gene deleted? Is that translocation present? Array comparative genomic hybridization (array CGH) goes further, scanning the entire genome for gains or losses of DNA segments at much higher resolution than a karyotype can achieve.22PubMed. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays Array CGH has been used to catalog copy-number variation across populations, including a study that interrogated genomes from Korean, Chinese, and Japanese individuals using an ultra-high-resolution platform with 24 million probes.23Nature Genetics. Discovery of common Asian copy number variants using integrated high-resolution array CGH and massively parallel DNA sequencing
The newest frontier is optical genome mapping (OGM), which images very long single molecules of DNA and uses fluorescent labels at specific sequence motifs to detect structural variants, copy-number changes, and complex rearrangements. A study of 85 patient samples with previously diagnosed chromosomal abnormalities found that OGM detected every single reported aberration, reaching 100 percent concordance with standard diagnostic results.24American Journal of Human Genetics. Next-Generation Cytogenetics: Comprehensive Assessment of 85 Cases of Constitutional Chromosomal Abnormalities by Optical Genome Mapping Because the DNA molecules analyzed by OGM are extremely long, they tend to span both sides of a structural change, making it possible to pinpoint exactly where a rearrangement occurred and how the pieces fit together.25PubMed Central. Optical Genome Mapping: A New Tool for Cytogenomic Analysis
Long-read DNA sequencing is also pushing into cytogenetic territory. A technical assessment using a mantle cell lymphoma cell line showed that long-read nanopore sequencing achieved about 99 percent copy-number reproducibility at fine resolution between replicates and 98 percent agreement with conventional short-read sequencing, while also resolving a well-known cancer-driving translocation with far greater detail.26PubMed Central. Toward Cytogenomics: Technical Assessment of Long-Read Nanopore Whole-Genome Sequencing for Detecting Large Chromosomal Alterations in Mantle Cell Lymphoma These tools are beginning to merge cytogenetics and genomics into a single discipline sometimes called cytogenomics.
Mosaicism and Its Detection Challenges
Not every cell in a person’s body necessarily carries the same set of chromosomes. Somatic mosaicism, in which some cells have a genetic change and others do not, can arise from errors during early embryonic cell division or accumulate later in life. Mosaic chromosome abnormalities can produce features that range from barely noticeable to clinically significant, depending on which tissues carry the abnormal cells and what fraction of cells are affected.
Detecting mosaicism has historically been difficult because standard tests might miss a change present in only a small percentage of cells. Advances in high-throughput sequencing have made it possible to pick up mosaic variants at lower levels than before, and mosaicism is now being recognized more frequently as a result.27PubMed Central. Detecting somatic mosaicism: considerations and clinical implications This matters clinically: a person with mosaic Turner syndrome may have much milder symptoms than someone with a uniform 45,X karyotype, and cancer cells often accumulate new chromosome changes over time, creating a mosaic tumor that evolves under treatment.
How Human Chromosome 2 Tells an Evolutionary Story
One of the most striking findings in cytogenetics has nothing to do with disease. Humans have 46 chromosomes, but chimpanzees, gorillas, and orangutans all have 48. Where did the missing pair go? The answer is that two ancestral ape chromosomes fused end-to-end to form human chromosome 2. The evidence is written in the DNA itself: at the fusion site on chromosome 2, researchers found head-to-head arrays of telomeric repeat sequences, the kind of DNA normally found only at chromosome tips, sitting in the middle of the chromosome where they do not belong.28PubMed. Origin of human chromosome 2: an ancestral telomere-telomere fusion Nearby, remnants of an ancient centromere (the region where chromosomes are normally pinched during cell division) can be found, now inactive.29Molecular Biology and Evolution. Centromere Destiny in Dicentric Chromosomes: New Insights from the Evolution of Human Chromosome 2 Ancestral Centromeric Region
More recent analysis has revised the estimated timing of this fusion. Earlier estimates placed it as far back as 4.5 million years ago, but a 2022 study that examined patterns of DNA substitution around the fusion site estimated it occurred closer to 0.9 million years ago, with a confidence interval of 0.4 to 1.5 million years ago.30PubMed Central. Revised time estimation of the ancestral human chromosome 2 fusion If that revised date holds, the fusion would have occurred well after the human lineage had already split from other great apes, making it a distinctly human chromosomal event rather than one shared with our last common ancestor.
Polyploidy in Plants
While having an entire extra set of chromosomes is almost always lethal in animals, it is common and often beneficial in plants. Polyploidy, the condition of carrying three or more complete chromosome sets, is a major driver of plant evolution and agricultural development. Many familiar crops, including wheat, cotton, and strawberries, are polyploid. Whole-genome duplication can generate new gene combinations and regulatory changes that give polyploid plants enhanced tolerance to drought, heat, salt, and disease.31PubMed Central. Genome evolution through polyploidy: Enhancing plant stress resilience in agriculture Cytogenetic tools, from basic chromosome counting to modern molecular methods, are essential for characterizing polyploid crops and for plant breeding programs that deliberately create new polyploids.
Telomeres and Chromosome Stability
Telomeres, the protective caps at the ends of chromosomes, are themselves a cytogenetic concern. Each time a cell divides, its telomeres shorten slightly. When they get critically short, the cell typically stops dividing or self-destructs. This acts as a built-in tumor-suppression mechanism, because it limits how many times a cell can replicate.32Trends in Genetics. Telomere dynamics in genome stability But the relationship between telomeres and cancer is a double-edged sword: if telomere-shortened cells bypass the normal shutdown signals instead of stopping, their unprotected chromosome ends can fuse with one another, creating the kind of chromosomal chaos that fuels cancer progression.33Nature Reviews Molecular Cell Biology. Telomeres in cancer: tumour suppression and genome instability
Where Chromosomes Sit in the Nucleus
Cytogenetics has traditionally been about what chromosomes look like when spread on a glass slide, but a growing area of research examines where chromosomes sit relative to each other inside the intact nucleus. Chromosomes are not tangled together like spaghetti. Each one occupies its own territory, and the positioning of these territories is not random. Studies using sequential labeling of up to ten chromosome territories and computer imaging have revealed that different cell types arrange their chromosomes in distinct spatial networks, and that these arrangements change during the cell cycle, when cells specialize, and during cancer progression.34PubMed Central. Chromosome territories and the global regulation of the genome The fact that certain chromosomes tend to sit near each other in normal cells may help explain why specific translocations are common in particular types of cancer: chromosomes that are neighbors are more likely to swap pieces when breaks occur.
Radiation Biodosimetry
Cytogenetics also serves as a biological dosimeter. After a radiation accident or suspected overexposure, doctors can draw a blood sample, culture the white blood cells, and look for specific types of chromosome damage, such as rings or fragments, that are characteristic of radiation exposure. Cytogenetic biodosimetry holds a unique position among the tools available for estimating radiation dose because it directly measures biological damage rather than relying solely on physical instruments that might not have been present at the time of exposure.35PubMed Central. Cytogenetic biological dosimetry assays: recent developments and updates This application remains critical for emergency preparedness and for evaluating occupational exposures in nuclear industry workers.